Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-04-02

FDA Approved: BENAZEPRIL HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for benazepril hydrochloride from Aurobindo Pharma Limited, indicating an update to an already approved drug product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Benazepril hydrochloride (Benazepril hydrochloride)

Snippet

SUPPL AP for BENAZEPRIL HYDROCHLORIDE (BENAZEPRIL HYDROCHLORIDE)